Brainsway
$14.98
27
+$0.02+0.13% 17:44 Today
Statistics
Day High
15.16
Day Low
14.79
52W High
17.35
52W Low
5.68
Volume
779,038
Avg. Volume
-
Mkt Cap
601.14M
P/E Ratio
69.05
Dividend Yield
-
Dividend
-
Earnings
13AugExpected
Q4 2023
Q1 2024
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.03
-0
0.02
0.05
Expected EPS
0.05
Actual EPS
0.05
Financials
14.5%Profit Margin
Profitable52.23MRevenue
7.58MNet Income
Analyst Ratings
17.00Average Price Target
The highest estimate is 17.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow BWAY. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap305.1B
Medtronic
MDT
Mkt Cap106.49B
Neogen
NEOG
Mkt Cap2.07B
Abbvie
ABBV
Mkt Cap461.26B
Johnson & Johnson
JNJ
Mkt Cap633.19B
Teamshares
TMS
Mkt Cap0
Teva- Pharmaceutical Industries
TEVA
Mkt Cap40.34B
LivaNova
LIVN
Mkt Cap4.59B
About
BrainsWay Ltd. develops and distributes non-invasive neurostimulation therapies that address a broad spectrum of mental health and neurological conditions. The company operates globally, with a presence in the United States, Europe, and Israel, among other international markets. Its primary offering is the Deep Transcranial Magnetic Stimulation (dTMS) platform technology, which provides treatment for various ailments including major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post-stroke rehabilitation, and Parkinson's disease. BrainsWay's clientele primarily comprises medical professionals, hospitals, and medical centers specializing in psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Show more...
CEO
Mr. Hadar Levy
Employees
120
Country
Israel
ISIN
US10501L1061
Listings
0 Comments
Share your thoughts
FAQ
What is Brainsway stock price today?▼
The current price of BWAY is $14.98 USD — it has increased by +0.13% in the past 24 hours. Watch Brainsway stock price performance more closely on the chart.
What is Brainsway stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Brainsway stocks are traded under the ticker BWAY.
Is Brainsway stock price growing?▼
BWAY stock has fallen by -1.25% compared to the previous week, the month change is a +3.95% rise, over the last year Brainsway has showed a +130.77% increase.
What is Brainsway market cap?▼
Today Brainsway has the market capitalization of 601.14M
What were Brainsway earnings last quarter?▼
BWAY earnings for the last quarter are 0.05 USD per share, whereas the estimation was 0.05 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Brainsway revenue for the last year?▼
Brainsway revenue for the last year amounts to 52.23M USD.
What is Brainsway net income for the last year?▼
BWAY net income for the last year is 7.58M USD.
How many employees does Brainsway have?▼
As of July 09, 2026, the company has 120 employees.
In which sector is Brainsway located?▼
Brainsway operates in the Health & Wellness sector.
When did Brainsway complete a stock split?▼
The last stock split for Brainsway was on March 03, 2026 with a ratio of 1:1.
Where is Brainsway headquartered?▼
Brainsway is headquartered in Jerusalem, Israel.